A thiol-alkyne click chemistry-driven lipoic acid precise delivery platform for targeted therapy of cerebral ischemic stroke via redox homeostasis restoration and neuroinflammatory cascade suppression
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
References (42)
Show source-provided references
1. Leeuw, stroke10.1016/S0140-6736(24)00642-1 ↗
2. Global epidemiology of stroke and access to acute ischemic stroke interventions10.1212/WNL.0000000000012781 ↗
3. Neurovascular protection by adropin in experimental ischemic stroke through an endothelial nitric oxide synthase-dependent mechanism10.1016/j.redox.2021.102197 ↗
4. Neutrophil extracellular traps promote tPA-induced brain hemorrhage via cGAS in mice with stroke10.1182/blood.2020008913 ↗
5. Edaravone-loaded poly (amino acid) nanogel inhibits ferroptosis for neuroprotection in cerebral ischemia injury
6. Artificial microglia nanoplatform loaded with anti-RGMa in acoustic/magnetic feld for recanalization and neuroprotection in acute ischemic stroke10.1002/advs.202410529 ↗
7. The impact of cytokines in neuroinflammation-mediated stroke10.1016/j.cytogfr.2024.06.002 ↗
8. Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions10.1038/s41392-022-01064-1 ↗
9. Glutamate acts on acid-sensing ion channels to worsen ischaemic brain injury10.1038/s41586-024-07684-7 ↗
10. Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets10.1038/s41392-023-01688-x ↗
11. Mitochondria and cell death10.1038/s41556-024-01429-4 ↗
12. Exposure of the inner mitochondrial membrane triggers apoptotic mitophagy10.1038/s41418-024-01260-2 ↗
13. Brain endothelial GSDMD activation mediates inflammatory BBB breakdown10.1038/s41586-024-07314-2 ↗
14. Lipidomic analysis identifies long-chain acylcarnitine as a target for ischemic stroke10.1016/j.jare.2023.08.007 ↗
15. Neuroinflammation across neurological diseases10.1126/science.adx0043 ↗
16. Profiling the mouse brain endothelial transcriptome in health and disease models reveals a core blood–brain barrier dysfunction module10.1038/s41593-019-0497-x ↗
17. Analysis of brain and blood single-cell transcriptomics in acute and subacute phases after experimental stroke10.1038/s41590-023-01711-x ↗
18. Neuroprotective effects of synthetic borneol and natural borneol based on the neurovascular unit against cerebral ischaemic injury10.1093/jpp/rgab167 ↗
19. l-borneol promotes neurovascular unit protection in the subacute phase of transient middle cerebral artery occlusion rats: p38-MAPK pathway activation, anti-inflammatory, and anti-apoptotic effect10.1002/ptr.7878 ↗
20. l-Borneol and d-Borneol promote transdifferentiation of astrocytes into neurons in rats by regulating Wnt/Notch pathway to exert neuroprotective effect during recovery from cerebral ischaemia10.1016/j.phymed.2022.154583 ↗
21. Advances and perspectives on pharmacological activities and mechanisms of the monoterpene borneol10.1016/j.phymed.2024.155848 ↗
22. Htd2 deficiency-associated suppression of α-lipoic acid production provokes mitochondrial dysfunction and insulin resistance in adipocytes10.1016/j.redox.2021.101948 ↗
23. Mitochondrial fatty acid synthesis is an emergent central regulator of mammalian oxidative metabolism10.1016/j.cmet.2023.11.017 ↗
24. Dissecting the process of human neutrophil lineage determination by using alpha-lipoic acid inducing neutrophil deficiency model10.1016/j.redox.2022.102392 ↗
25. α-lipoic acid ameliorates consequences of copper overload by up-regulating selenoproteins and decreasing redox misbalance10.1073/pnas.2305961120 ↗
26. Chemoproteomic target deconvolution reveals histone deacetylases as targets of (R)-lipoic acid10.1038/s41467-023-39151-8 ↗
27. Dysregulation of mitochondrial α-ketoglutarate dehydrogenase leads to elevated lipid peroxidation in CHCHD2-linked Parkinson's disease models10.1038/s41467-025-57142-9 ↗
28. Antipsychotics and dietary interventions: pharmacodynamics, pharmacokinetics, and synergisms in therapy10.1016/j.pharmr.2025.100061 ↗
29. Conjugation chemistry markedly impacts toxicity and biodistribution of targeted nanoparticles, mediated by complement activation10.1002/adma.202409945 ↗
30. Protein design meets biosecurity10.1126/science.ado1671 ↗
31. Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects10.1038/s41392-024-01969-z ↗
32. Overcoming the blood–brain barrier: the role of nanomaterials in treating neurological diseases10.1002/adma.201801362 ↗
33. Functionalized nanomaterials capable of crossing the blood–brain barrier10.1021/acsnano.3c10674 ↗
34. Biomimetic nanomotors for deep ischemia penetration and ferroptosis inhibition in neuroprotective therapy of ischemic stroke10.1002/adma.202409176 ↗
35. Microglia as integrators of brain-associated molecular patterns10.1016/j.it.2024.03.009 ↗
36. Microglial CMPK2 promotes neuroinflammation and brain injury after ischemic stroke
37. Toll-like receptor signaling rewires macrophage metabolism and promotes histone acetylation via ATP-citrate lyase10.1016/j.immuni.2019.11.009 ↗
38. Nanomaterial-based repurposing of macrophage metabolism and its applications10.1007/s40820-024-01455-9 ↗
39. Metabolic reprogramming in ischemic stroke: when glycolytic overdrive meets lipid storm10.1038/s41419-025-08114-w ↗
40. Dendritic hydrogels induce immune modulation in human keratinocytes and effectively eradicate bacterial pathogens10.1021/jacs.1c07492 ↗
41. Tumor noninvasive and target embolization therapy platform by intravenous injection based on acidic microenvironment-responsive hyperbranched poly(amino acid)s10.1021/acscentsci.0c00506 ↗
42. Mechanistic investigation on oxidative degradation of ROS-responsive thioacetal/thioketal moieties and their implications